Intracorneal melatonin delivery using 2-hydroxypropyl- β-cyclodextrin ophthalmic solution for granular corneal dystrophy type 2
In conclusion, MT/HPβCD formulations can lower irritation, enhance MT stability, and improve therapeutic efficacy. Graphical abstract
Source: International Journal of Pharmaceutics - Category: Drugs & Pharmacology Source Type: research
More News: Antidoxidants | Drugs & Pharmacology | Melatonin | Opthalmology | Reflex Sympathetic Dystrophy | Study